Equity index movers 31 May 2017

Global markets were fairly quiet at the end of the month, the FTSE 100 closed down less than 0.1%, after making an earlier failed attempt at a new record high. “Sell in May and go away”, so the saying goes, but not this month. Although it ended on a whimper, May has wrought some decent returns for the FTSE 100, which has risen more than 4%. Across the Atlantic gains were slimmer, the Dow rose less than 1% over the month after the Trump slump. Although there were significant inflows into European indices, the Eurostoxx index actually fell over the course of the month.

What’s weighing on the FTSE?

The failed attempt at another record high for the FTSE 100 was scuppered by weakness in the energy and materials sectors, with financials and real estate also having a bad day. In contrast, the healthcare and telecoms sectors’ were the top performers, suggesting an overall risk off tone and an investor desire to own defensive stocks.

Interestingly, miner Rangold was the top performer on the day, rising nearly 3%, followed by Mediclinic (Tuesday’s weakest performer) and Barratt Developments. The housing sector is looking cheap on a P/E basis, which could bode well for this sector. When we get to this mature phase of a market rally, investors’ tend to be on the lookout for equities with a cheaper valuation, which could make the housing sector an attractive investment opportunity for some time to come.

In contrast, Rio Tinto, BHP Billiton and Glencore were the weakest performers, as the oil and oil products markets saw sharp declines; Brent and WTI were down more than 2% on the day. Sugar and coffee prices were also sharply lower. If we continue to see declines in the commodity space, we would expect further downside for the FTSE 100.

Financials weigh on the Dow for another day

It was another day of modest losses for US indices. The Dow was dragged down yet again by the financial sector, with Goldman Sachs and JP Morgan experiencing another day of selling, on the back of the flattening US yield curve. On the upside, Pfizer was the top performer, which also suggests a defensive tone to investor behaviour.

As we start a new month, there are signs that the global stock market rally is starting to slow down. That has been evident in the US and Europe, however, the FTSE 100 managed to push ahead in May. This makes the UK index vulnerable as we start a new month, in our view, due to upcoming domestic political risks and struggling commodity and financial sectors that have large weightings in the FTSE 100.

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. CFD and Forex Trading are leveraged products and your capital is at risk. They may not be suitable for everyone. Please ensure you fully understand the risks involved by reading our full risk warning.

City Index is a trading name of StoneX Financial Ltd. Head and Registered Office: 1st Floor, Moor House, 120 London Wall, London, EC2Y 5ET. StoneX Financial Ltd is a company registered in England and Wales, number: 05616586. Authorised and regulated by the Financial Conduct Authority. FCA Register Number: 446717.

City Index is a trademark of StoneX Financial Ltd.

The information on this website is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement.